How much cash does Tectonic Therapeutics generate?

Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.

What is Tectonic Therapeutics's free cash flow?

After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.

Where does Tectonic Therapeutics's cash flow data come from?

Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Tectonic Therapeutics TECX Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$83.49M-12.6%	-$74.15M-10.2%	-$67.3M-2.0%	-$65.98M-12.5%	-$58.67M-1.2%
Depreciation and amortization	$1.32M-4.1%	$1.38M-11.3%	$1.55M-5.0%	$1.63M+0.2%	$1.63M-1.0%
Stock-based compensation	$11.6M+10.5%	$10.5M+21.7%	$8.63M+15.6%	$7.46M+41.4%	$5.27M+51.0%
Gain (loss) on sale of assets	-$176K-15.0%	-$153K0.0%	-$153K-155%	-$60K—	——
Change in accounts payable	——	——	——	$370K+127%	-$1.35M+5.2%
Change in accrued liabilities	——	——	——	——	-$10.44M-85.1%
Change in other assets	——	——	——	——	-$534K+1.8%
Non-cash operating lease expense	$2.1M-0.7%	$2.12M—	——	——	——
Change in operating lease liabilities	-$1.89M+17.7%	-$2.3M—	——	——	——
Net cash from operating activities	-$65.41M-8.9%	-$60.08M+3.8%	-$62.44M+2.8%	-$64.23M-2.1%	-$62.89M-6.4%
Capital expenditures	——	——	——	——	$179K+14.7%
Proceeds from sale of property, plant and equipment	——	——	——	——	——
Net cash from investing activities	-$130K+5.8%	-$138K+2.1%	-$141K-10.2%	-$128K+28.5%	-$179K-14.7%
Proceeds from issuance of common stock	$359K-70.8%	$1.23M-40.6%	$2.07M-3.3%	$2.14M-17.4%	$2.59M+59.6%
Payments for finance leases	$476K-2.7%	$489K+2.5%	$477K+0.6%	$474K-0.2%	$475K0.0%
Taxes paid for net share settlement	——	——	——	$17K—	$0—
Net cash from financing activities	——	——	——	——	——
Effect of exchange rate changes on cash	$4K+104%	-$95K—	——	——	——
Net increase (decrease) in cash	——	——	——	——	——
Interest paid	——	——	——	——	——
Accrued expenses and other liabilities	——	——	——	——	-$10.44M-85.1%
Operating lease liabilities	-$1.89M+17.7%	-$2.3M—	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	$1.26M-60.5%
Operating lease right-of-use asset amortization	$2.1M-0.7%	$2.12M—	——	——	——
Finance Lease, Principal Payments	$476K-2.7%	$489K+2.5%	$477K+0.6%	$474K-0.2%	$475K0.0%
Net proceeds from sales of subsidiary shares	——	——	——	——	——
Common stock issuance for private placement	——	——	——	——	$177.27M—
Increase Decrease In Operating Lease Liability	-$1.89M+17.7%	-$2.3M—	——	——	——
Leased assets obtained in exchange for operating lease liabilities	——	——	——	——	$0—
Deferred Offering Costs Included In Accrued Expenses And Other Liabilities	——	$35K+33.3%	$26.25K+50.0%	$17.5K+100%	$8.75K—
Private Placement Costs Included In Accrued Expenses And Other Current Liabilities	——	——	——	——	——
Purchases Of Property And Equipment Included In Accounts Payable	——	——	——	——	——
Receivable Related To The Sale Of Property And Equipment	——	——	——	——	——
Free cash flow	-$65.61M-8.8%	-$60.29M+3.8%	-$62.65M+2.7%	-$64.41M-2.1%	-$63.07M-6.5%
Free cash flow	-$65.61M-8.8%	-$60.29M+3.8%	-$62.65M+2.7%	-$64.41M-2.1%	-$63.07M-6.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Tectonic Therapeutics generate?: Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.
What is Tectonic Therapeutics's free cash flow?: After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.
Where does Tectonic Therapeutics's cash flow data come from?: Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.